Avid Studio Suite Helps Ireland’s TV3 Group Deliver High-Impact Broadcasting
Jan 04, 2017 13:45 pm UTC| Business
BURLINGTON, Mass., Jan. 04, 2017 -- Avid® (Nasdaq: AVID) today announced that the Republic of Ireland’s leading commercial broadcaster, TV3, has implemented next-generation graphics solutions from the Avid Studio Suite....
Global Energy Management Systems Market will reach USD 70.93 Billion by 2022: Zion Market Research
Jan 04, 2017 13:43 pm UTC| Business
Sarasota, FL, Jan. 04, 2017 -- Zion Research has published a new report titled “Energy Management Systems Market by Software (Utility, Industrial, Residential and Enterprises Energy Management): Global Industry...
McDermott awarded offshore EPCI contract from Saudi Aramco
Jan 04, 2017 13:32 pm UTC| Business
McDermott to provide fast-track EPCI solution to meet tight schedule Third fast-track project awarded from Saudi Aramco to McDermott in past 18 monthsAward builds on McDermott’s successful track record of schedule...
McDermott awarded offshore EPCI contract from Saudi Aramco
Jan 04, 2017 13:32 pm UTC| Business
McDermott to provide fast-track EPCI solution to meet tight schedule Third fast-track project awarded from Saudi Aramco to McDermott in past 18 monthsAward builds on McDermott’s successful track record of schedule...
McDermott awarded offshore EPCI contract from Saudi Aramco
Jan 04, 2017 13:32 pm UTC| Business
McDermott to provide fast-track EPCI solution to meet tight schedule Third fast-track project awarded from Saudi Aramco to McDermott in past 18 monthsAward builds on McDermott’s successful track record of schedule...
Jan 04, 2017 13:32 pm UTC| Business
REDWOOD CITY, Calif., Jan. 04, 2017 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology therapeutics, today...
Jan 04, 2017 13:32 pm UTC| Business
REDWOOD CITY, Calif., Jan. 04, 2017 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology therapeutics, today...